SelectScience E-Book: Understanding the Complex Landscape of Bioconjugates

A complete guide for selecting the right fit-for-purpose strategy for your ADC, AOC, and RDC

Bioconjugates are a rapidly expanding therapeutic modality demonstrating tremendous benefit for cancer patients already, and with significant promise in inflammatory, infectious, and rare diseases. Key to the successful development of bioconjugates is the selection of an appropriate conjugation strategy.

In this eBook, our Vice President of ADCs and Bioconjugates, Dr. Nicolas Camper, and SVP and Scientific Leader, Dr. Petra Dieterich, review and discuss the main categories of therapeutic bioconjugates, focusing on their key required characteristics or target product profile (TPP). Including key considerations for selecting the most appropriate conjugation strategy for each application and insights into technological options, along with real-world examples of bioconjugates in clinical development and in-market.

Download the E-book